Scottish Mortgages raises $400m through private placement

To maintain appropriate level of gearing

Kathleen Gallagher
clock • 2 min read

The board of the £18.3bn Scottish Mortgage investment trust has raised $400m through a private placement to provide “long-term financing”.

In a stock exchange announcement, the board said it increased the level of borrowings "in order to maintain what it believes to be the appropriate level of gearing of the portfolio". Analysts at Numis highlighted that "Scottish Mortgage has added to its structural debt a number of times in recent years, which reflects the Board's aim to have gearing at c.10%, but it has historically been marginally below this due to the growth in assets of the company reducing the level of gearing as a proportion of assets." The new private placement consists of three notes: one 30-year note for $175m...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot